Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine | Gastroenterology

Cervical Cancer Clinical Trials

A listing of Cervical Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

District of Columbia

Georgetown University Hospital
Washington District of Columbia 20007

A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts

Childrens National Medical Center
Washington District of Columbia 20010

A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts

Iowa

GSK Investigational Site
Iowa City Iowa 52242

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

Kansas

GSK Investigational Site
Wichita Kansas 67207

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

Massachusetts

Dana-Farber Cancer Institute
Boston Massachusetts 02215

A clinical trial to evaluate treatments using GSK1120212 (trametinib) and GSK2141795 for patients with Cervical Cancer

New Mexico

GSK Investigational Site
Albuquerque New Mexico 87131

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

New York

Memorial Sloan-Kettering Cancer Center
New York New York 10022

A clinical trial seeking patients for a research study of compound 31543 Calcitriol

Ohio

Athens Ohio 45701

Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer

Gallipolis Ohio 45631

Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer

Logan Ohio 43138

Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer

Pomeroy Ohio 45769

Patients are needed to participate in a clinical research study to evaluate Uterine Cervical Cancer

Oklahoma

Oklahoma University
Oklahoma City Oklahoma 73104

A clinical study for patients with Cervical Cancer

Texas

UT MD Anderson Cancer Center
Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Interview and Questionnaire

Washington

GSK Investigational Site
Wenatchee Washington 98801

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

Belgium

University Hospitals Leuven
Leuven 31 16 34 19 98

Patients are needed to participate in a clinical research study of KPT-330 to evaluate Ovarian Carcinoma, Endometrial Carcinoma or Cervical Carcinoma

Brazil

GSK Investigational Site
Campinas 13083-970

A clinical research study of GSK Biologicals' HPV vaccine 580299 and Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine for the treatment of Infections, Papillomavirus

GSK Investigational Site
Porto Alegre Rio Grande Do Sul 90035003

A clinical research study of GSK Biologicals' HPV vaccine 580299 and Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine for the treatment of Infections, Papillomavirus

GSK Investigational Site
Ribeirão Preto São Paulo 14049-900

A clinical research study of GSK Biologicals' HPV vaccine 580299 and Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine for the treatment of Infections, Papillomavirus

GSK Investigational Site
São Paulo 03015000

A clinical research study of GSK Biologicals' HPV vaccine 580299 and Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine for the treatment of Infections, Papillomavirus

Canada

GSK Investigational Site
Halifax Nova Scotia B3K 6R8

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

Research Site
Montreal Quebec

Patients are needed to participate in a clinical research study of AZD5363

GSK Investigational Site
Sherbrooke Quebec J1H 1Z1

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

GSK Investigational Site
Truro Nova Scotia B2N 1L2

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

GSK Investigational Site
Vancouver British Columbia V6H 3N1

Patients are needed to participate in a clinical research study of Gynaecological follow-up, Cervarix™ and Placebo control to evaluate Human Papillomavirus Infection or Cervical Neoplasia

China

Cancer Institute & Hospital Chinese Academy of Medical Sciences
Beijing 100021

A clinical trial seeking patients for a research study of HPV Vaccine and HEV vaccine

Colombia

Universidad de Antioquia
Medellin Antioquia

Patients are needed to participate in a clinical research study of HPV test, COLPOSCOPY and cytology to evaluate Cervical Abnormalities, Cervical Intraepithelial Neoplasia Grade 2/3 or Cervical Cancer

Croatia

University Hospital for Infectious Diseases, Croatia
Zagreb 10 000

A clinical trial seeking patients for a research study for the treatment of Cervical Cancer

Finland

GSK Investigational Site
Aanekoski 44100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Hameenlinna 13100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Helsinki 00100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Hyvinkaa 05800

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Iisalmi 74100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

View More »

GSK Investigational Site
Jamsa 42100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Jarvenpaa 04400

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Joensuu 80130

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Jyvaskyla 40100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Kajaani 87100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Kemi 94100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Kokkola 67100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Kotka 48100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Kotka 48100

Patients are needed to participate in a clinical research study of Gynaecological follow-up to evaluate Human Papillomavirus (HPV) Type 16/18 Infections or Cervical Neoplasia

GSK Investigational Site
Kouvola 45100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Kuopio 70100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Kuusamo 93600

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Lahti 15110

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Lappeenranta 53100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Lohja 08100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Mikkeli 50100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Oulu 90220

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

GSK Investigational Site
Pori 28100

A Phase 4 clinical study for patients with Human Papillomavirus (HPV) Infection

First 1 2 Last